Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2017-06-26 | Rajinder Kumar, Ph.D. has served as the Chairman and Chief Executive Officer of MeRaD Pharmaceutical Ltd. in Cambridge U.K. since May 2009. Based on Dr. Kumar’s management experience in the pharmaceutical industry, our Board believes that Dr. Kumar has the appropriate set of skills to serve as a member of the Board. The governance committee currently consists of James R. McNab, Jr. (chair), M. David MacFarlane and Rajinder Kumar. Rajinder Kumar 2016 Total Compensation $0. |
| 2018-07-02 | Rajinder Kumar, Ph.D. has served as the chairman and chief executive officer of MeRaD Pharmaceutical Ltd. in Cambridge U.K. since May 2009. The governance committee consists of James R. McNab, Jr., Rajinder Kumar and M. David MacFarlane who meet the independence requirements and standards currently established by the NYSE MKT. The following table summarizes compensation that our non-employee directors earned during 2017 for services as members of our Board. Rajinder Kumar, Ph.D. earned $74,835 in total compensation. |
Data sourced from SEC filings. Last updated: 2026-02-03